Mesenchymal stem cells offer advantages over hematopoietic stem cells as they do not require cross-matching, lowering the risk of rejection. However, early-generation MSCs can still be immunogenic, but second-generation gene-edited MSCs have improved longevity. In the future, advancements in regenerative medicine may lead to full organ regeneration, with cartilage anticipated as one of the first organs to be successfully regenerated using tissue engineering and embedded stem cells.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode